196 related articles for article (PubMed ID: 2435444)
1. Fast anterograde axonal transport in wasted and non-wasted diabetic rats; effects of aldose reductase inhibition.
Whiteley SJ; Townsend J; Tomlinson DR; Willars GB
Diabetes Res; 1986 Nov; 3(9):447-52. PubMed ID: 2435444
[TBL] [Abstract][Full Text] [Related]
2. Reduced anterograde and retrograde accumulation of axonally transported phosphofructokinase in streptozotocin-diabetic rats: effects of insulin and the aldose reductase inhibitor 'Statil'.
Willars GB; Calcutt NA; Tomlinson DR
Diabetologia; 1987 Apr; 30(4):239-43. PubMed ID: 2439402
[TBL] [Abstract][Full Text] [Related]
3. Axonal transport and tissue contents of substance P in rats with long-term streptozotocin-diabetes. Effects of the aldose reductase inhibitor 'statil'.
Robinson JP; Willars GB; Tomlinson DR; Keen P
Brain Res; 1987 Nov; 426(2):339-48. PubMed ID: 2446712
[TBL] [Abstract][Full Text] [Related]
4. Treatment with an aldose reductase inhibitor can reduce the susceptibility of fast axonal transport following nerve compression in the streptozotocin-diabetic rat.
Dahlin LB; Archer DR; McLean WG
Diabetologia; 1987 Jun; 30(6):414-8. PubMed ID: 2445613
[TBL] [Abstract][Full Text] [Related]
5. Slow orthograde axonal transport of radiolabelled protein in sciatic motoneurones of rats with short-term experimental diabetes: effects of treatment with an aldose reductase inhibitor or myo-inositol.
Mayer JH; Tomlinson DR; McLean WG
J Neurochem; 1984 Nov; 43(5):1265-70. PubMed ID: 6208327
[TBL] [Abstract][Full Text] [Related]
6. Studies on peripheral nerve and lens in long-term experimental diabetes: effects of the aldose reductase inhibitor statil.
Willars GB; Townsend J; Tomlinson DR; Compton AM; Churchill RD
Metabolism; 1988 May; 37(5):442-9. PubMed ID: 2452959
[TBL] [Abstract][Full Text] [Related]
7. Prevention of defects of axonal transport and nerve conduction velocity by oral administration of myo-inositol or an aldose reductase inhibitor in streptozotocin-diabetic rats.
Mayer JH; Tomlinson DR
Diabetologia; 1983 Nov; 25(5):433-8. PubMed ID: 6197336
[TBL] [Abstract][Full Text] [Related]
8. Slow component-a of axonal transport, nerve myo-inositol, and aldose reductase inhibition in streptozocin-diabetic rats.
Tomlinson DR; Sidenius P; Larsen JR
Diabetes; 1986 Apr; 35(4):398-402. PubMed ID: 2420664
[TBL] [Abstract][Full Text] [Related]
9. Increased nerve polyol levels in experimental diabetes and their reversal by Sorbinil.
Whiting PH; Ross IS
Br J Exp Pathol; 1988 Oct; 69(5):697-702. PubMed ID: 3143396
[TBL] [Abstract][Full Text] [Related]
10. Prevention of defective axonal transport in streptozocin-diabetic rats by treatment with "Statil" (ICI 128436), an aldose reductase inhibitor.
Tomlinson DR; Townsend J; Fretten P
Diabetes; 1985 Oct; 34(10):970-2. PubMed ID: 2412918
[TBL] [Abstract][Full Text] [Related]
11. Properties of ICI 128,436, a novel aldose reductase inhibitor, and its effects on diabetic complications in the rat.
Stribling D; Mirrlees DJ; Harrison HE; Earl DC
Metabolism; 1985 Apr; 34(4):336-44. PubMed ID: 3920474
[TBL] [Abstract][Full Text] [Related]
12. The effect of aldose reductase inhibition on the pattern of nerve conduction deficits in diabetic rats.
Cameron NE; Cotter MA; Robertson S
Q J Exp Physiol; 1989 Nov; 74(6):917-26. PubMed ID: 2512591
[TBL] [Abstract][Full Text] [Related]
13. Axonal transport and nerve conduction and their relation to nerve polyol and myo-inositol levels in spontaneously diabetic BB/D rats.
Mayer JH; Herberg L; Tomlinson DR
Neurochem Pathol; 1984-1985 Winter; 2(4):285-93. PubMed ID: 6085698
[TBL] [Abstract][Full Text] [Related]
14. Effect of aldose reductase inhibition on nerve conduction velocity and resistance to ischemic conduction block in experimental diabetes.
Price DE; Airey CM; Alani SM; Wales JK
Diabetes; 1988 Jul; 37(7):969-73. PubMed ID: 3133261
[TBL] [Abstract][Full Text] [Related]
15. Sorbitol metabolism in the retina, optic nerve, and sural nerve of diabetic rats treated with an aldose reductase inhibitor.
Naeser P; Brolin SE; Eriksson UJ
Metabolism; 1988 Dec; 37(12):1143-5. PubMed ID: 3143049
[TBL] [Abstract][Full Text] [Related]
16. The effects of an aldose reductase inhibitor upon the sorbitol pathway, fructose-1-phosphate and lactate in the retina and nerve of streptozotocin-diabetic rats.
Poulsom R; Mirrlees DJ; Earl DC; Heath H
Exp Eye Res; 1983 May; 36(5):751-60. PubMed ID: 6406254
[TBL] [Abstract][Full Text] [Related]
17. The effect of aldose reductase inhibitor, statil, on hyperpermeability of iridial vessels in experimental galactosemic rats.
Terubayashi H; Akagi Y
Jpn J Ophthalmol; 1989; 33(3):343-7. PubMed ID: 2507812
[TBL] [Abstract][Full Text] [Related]
18. Correction of nerve conduction and endoneurial blood flow deficits by the aldose reductase inhibitor, tolrestat, in diabetic rats.
Cotter MA; Cameron NE; Hohman TC
J Peripher Nerv Syst; 1998; 3(3):217-23. PubMed ID: 10959252
[TBL] [Abstract][Full Text] [Related]
19. Streptozotocin-induced diabetes causes metabolic changes and alterations in neurotrophin content and retrograde transport in the cervical vagus nerve.
Lee PG; Hohman TC; Cai F; Regalia J; Helke CJ
Exp Neurol; 2001 Jul; 170(1):149-61. PubMed ID: 11421592
[TBL] [Abstract][Full Text] [Related]
20. Ultrastructural observations on myelinated fibres in experimental diabetes: effect of the aldose reductase inhibitor ponalrestat given alone or in conjunction with insulin therapy.
Bhoyrul S; Sharma AK; Stribling D; Mirrlees DD; Peterson RG; Farber MO; Thomas PK
J Neurol Sci; 1988 Jun; 85(2):131-47. PubMed ID: 2968441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]